SARM1 activation triggers axon degeneration locally via NAD + destruction

Gerdts, Josiah, Brace, E.J., Sasaki, Yo, DiAntonio, Aaron, Milbrandt, Jeffrey·2015·Science

Cited by (594)

Items 201–300 of 594

  1. SARM1 Promotes Neurodegeneration and Memory Impairment in Mouse Models of Alzheimer's Disease
    Xuemeng Miao, Qian Wu, Siyu Du, Ludan Xiang, Siyao Zhou, Junzhe Zhu, Zirun Chen, Hui Wang, Xuyi Pan, Yiren Fan et al. · 2023 · Aging and Disease
  2. Calpain signaling: from biology to therapeutic opportunities in neurodegenerative disorders
    Elsayed Metwally, Hatim A. Al-Abbadi, Tarique Hussain, Ghulam Murtaza, Ahmed M. Abdellatif, Mahmoud Fadl el Mula Ahmed · 2023 · Frontiers in Veterinary Science
  3. Nutritional Supplements for the Treatment and Prevention of Sports-Related Concussion—Evidence Still Lacking
    Thomas H. Trojian, David H. Wang, John J. Leddy · 2017 · Current Sports Medicine Reports
  4. Vincristine- and bortezomib-induced neuropathies – from bedside to bench and back
    Stefanie Geisler · 2020 · Experimental Neurology
  5. Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
    Jefferson Antônio Leite, Bruno Ghirotto, Vitor Pedro Targhetta, Jean de Lima, Niels Olsen Saraiva Câmara · 2021 · British Journal of Pharmacology
  6. Multifaceted roles of SARM1 in axon degeneration and signaling
    Thomas J. Waller, Catherine A. Collins · 2022 · Frontiers in Cellular Neuroscience
  7. SIRT1 and NAD + precursors: Therapeutic targets in multiple sclerosis a review
    Vamshi K.C. Nimmagadda, Tapas Kumar Makar, Krish Chandrasekaran, Avinash Rao Sagi, Jayanta Ray, James William Russell, Christopher T. Bever · 2016 · Journal of Neuroimmunology
  8. Rapamycin maintains NAD+/NADH redox homeostasis in muscle cells
    Zhigang Zhang, He N. Xu, Siyu Li, Antonio Dávila, Karthikeyani Chellappa, James G. Davis, Yuxia Guan, David W. Frederick, Weiqing Chu, Huaqing Zhao et al. · 2020 · Aging
  9. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures
    Donald V. Bradshaw, Andrew K. Knutsen, Alexandru V. Korotcov, Genevieve M. Sullivan, Kryslaine L. Radomski, Bernard J. Dardzinski, Xiaomei Zi, Dennis P. McDaniel, Regina C. Armstrong · 2021 · Acta Neuropathologica Communications
  10. Nicotinic acid mononucleotide is an allosteric SARM1 inhibitor promoting axonal protection
    Yo Sasaki, Jian Zhu, Yun Yu Shi, Weixi Gu, Boštjan Kobe, Thomas Ve, Aaron DiAntonio, Jeffrey Milbrandt · 2021 · Experimental Neurology
  11. NAD+-consuming enzymes in immune defense against viral infection
    Jialin Shang, Michael R. Smith, Ananya Anmangandla, Hening Lin · 2021 · Biochemical Journal
  12. Axon morphogenesis and maintenance require an evolutionary conserved safeguard function of Wnk kinases antagonizing Sarm and Axed
    Azadeh Izadifar, Julien Courchet, Daniel M. Virga, Tine Verreet, Stevie Hamilton, Derya Ayaz, Anke Misbaer, Sofie Vandenbogaerde, Laloé Monteiro, Milan Petrovic et al. · 2021 · Neuron
  13. NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging
    Sabrina Wagner, Ravikumar Manickam, Marco A. P. Brotto, Srinivas M. Tipparaju · 2022 · Molecular and Cellular Biochemistry
  14. NAD+ Precursors Repair Mitochondrial Function in Diabetes and Prevent Experimental Diabetic Neuropathy
    Krish Chandrasekaran, Neda Najimi, Avinash Rao Sagi, Sushuma Yarlagadda, Mohammad Salimian, Muhammed Ikbal Arvas, Ahmad F. Hedayat, Yanni Kevas, Anand Kadakia, James William Russell · 2022 · International Journal of Molecular Sciences
  15. NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies
    Jonathan B. Lin, Rajendra S. Apte · 2018 · Progress in Retinal and Eye Research
  16. Metabolic aspects of neuronal degeneration: From a NAD+ point of view
    Yo Sasaki · 2018 · Neuroscience Research
  17. The Molecular Interplay between Axon Degeneration and Regeneration
    Marie‐Pier Girouard, Mardja Bueno, Victoria Julian, Sienna Drake, Alexandra B. Byrne, Alyson E. Fournier · 2018 · Developmental Neurobiology
  18. SARM1 deficiency up-regulates XAF1, promotes neuronal apoptosis, and accelerates prion disease
    Caihong Zhu, Bei Li, Karl Frontzek, Yingjun Liu, Adriano Aguzzi · 2019 · The Journal of Experimental Medicine
  19. The basic science of optic nerve regeneration
    Lindsay Fague, Yin Liu, Nicholas Marsh‐Armstrong · 2021 · Annals of Translational Medicine
  20. A phase transition enhances the catalytic activity of SARM1, an NAD+ glycohydrolase involved in neurodegeneration
    Heather S. Loring, Victoria L Czech, Janneke D. Icso, Lauren O'Connor, Sangram S. Parelkar, Alexandra B. Byrne, Paul R. Thompson · 2021 · eLife
  21. Sarm1-mediated neurodegeneration within the enteric nervous system protects against local inflammation of the colon
    Yue Sun, Qi Wang, Yi Wang, Wenran Ren, Ying Cao, Jiali Li, Xin Zhou, Wei Fu, Jing Hui Yang · 2021 · Protein & Cell
  22. Targeting NAD+ metabolism: dual roles in cancer treatment
    Jiaxin Yong, Songqing Cai, Zhao-Lei Zeng · 2023 · Frontiers in Immunology
  23. Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
    Claudia Alberti, Federica Rizzo, Alessia Anastasia, Giacomo P. Comi, Stefania Paola Corti, Elena Abati · 2024 · Neurobiology of Disease
  24. Mechanisms of injury-induced axon degeneration
    Chen Ding, Marc Hammarlund · 2019 · Current Opinion in Neurobiology
  25. Evolving Techniques in Peripheral Nerve Regeneration
    Steven T. Lanier, Jeffrey Ryan Hill, Christopher J. Dy, David M. Brogan · 2021 · The Journal Of Hand Surgery
  26. Models of axon regeneration in Drosophila
    E. J. Brace, Aaron DiAntonio · 2016 · Experimental Neurology
  27. Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules
    Saara Tikka, Evanthia Monogioudi, Athanasios Gotsopoulos, Rabah Soliymani, Francesco Pezzini, Enzo Scifo, Kristiina Uusi-Rauva, Jaana Tyynelä, Marc Baumann, Anu Jalanko et al. · 2015 · NeuroMolecular Medicine
  28. Therapeutic opportunities and pitfalls in the treatment of axon degeneration
    David J. Simon, Trent A. Watkins · 2018 · Current Opinion in Neurology
  29. Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies
    Alessandra Bolino, Maurizio D’Antonio · 2023 · Journal of the Peripheral Nervous System
  30. Touch Receptors Undergo Rapid Remodeling in Healthy Skin
    Kara L. Marshall, Rachel C. Clary, Yoshichika Baba, Rachel L. Orlowsky, Gregory J. Gerling, Ellen A. Lumpkin · 2016 · Cell Reports
  31. Axonal fusion: An alternative and efficient mechanism of nerve repair
    Brent Neumann, Casey Linton, Rosina Giordano-Santini, Massimo A. Hilliard · 2018 · Progress in Neurobiology
  32. The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis
    Thais Peclat, Bo Shi, John Varga, Eduardo N. Chini · 2020 · Current Opinion in Rheumatology
  33. TIR-domain enzymatic activities at the heart of plant immunity.
    Federica Locci, Jun-Li Wang, J. Parker · 2023 · Current opinion in plant biology
  34. TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance
    Martha R. C. Bhattacharya, Stefanie Geisler, Sara K. Pittman, Ryan A. Doan, Conrad Chris Weihl, Jeffrey Milbrandt, Aaron DiAntonio · 2016 · Journal of Neuroscience
  35. Axo‐glial interaction in the injured PNS
    Ruth Martha Stassart, Ashwin Woodhoo · 2020 · Developmental Neurobiology
  36. Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
    Pingting Liu, Wei Chen, Haowen Jiang, Haoliang Huang, Liping Liu, Fang Fang, Liang Li, Xue Feng, Dong Liu, Roopa Dalal et al. · 2023 · Molecular Therapy — Nucleic Acids
  37. Boosting mitochondrial health to counteract neurodegeneration
    Johannes Burtscher, Mario Romani, Greta Bernardo, Traian Popa, Elena Ziviani, Friedhelm Christoph Hummel, Vincenzo Sorrentino, Grégoire Paul Millet · 2022 · Progress in Neurobiology
  38. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer’s disease: genome-wide transcriptomic profiling and bioinformatics data mining
    Adva Hadar, Elena Milanesi, Alessio Squassina, Paola Niola, Caterina Chillotti, Metzada Pasmanik-Chor, Orly Yaron, Pavel Martasek E, Moshe Rehavi, Daphna Weissglas‐Volkov et al. · 2016 · Translational Psychiatry
  39. Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease
    Owen M. Peters, Alexandra Weiss, Jake Metterville, Lina Song, Robert A Logan, Gaynor Ann Smith, Michael A. Schwarzschild, Christian Mueller, Robert H. Brown, Marc Freeman · 2021 · Neurobiology of Disease
  40. Acute sources of mitochondrial NAD+ during respiratory chain dysfunction
    Christos Chinopoulos · 2020 · Experimental Neurology
  41. Implications of NAD + boosters in translational medicine
    Baeki E. Kang, Jun‐Yong Choi, Sokrates Stein, Dongryeol Ryu · 2020 · European Journal of Clinical Investigation
  42. The NAD+ precursor NMN activates dSarm to trigger axon degeneration in Drosophila
    Arnau Llobet Rosell, Maria Paglione, Jonathan Gilley, Magdalena Kocia, Giulia Perillo, Massimiliano Gasparrini, Lucia Cialabrini, Nadia Raffaelli, Carlo Angeletti, Giuseppe Orsomando et al. · 2022 · eLife
  43. Abnormal intraepidermal nerve fiber density in disease: A scoping review
    Sarah Thomas, Jonathan David Enders, A Kaiser, Luke Rovenstine, Lana L. Heslop, Will Hauser, Andrea L. Chadwick, Douglas E. Wright · 2023 · Frontiers in Neurology
  44. Roles of palmitoylation in axon growth, degeneration and regeneration
    Sabrina M. Holland, Gareth M. Thomas · 2017 · Journal of Neuroscience Research
  45. Peripheral mechanisms of peripheral neuropathic pain
    Paola Pacifico, James S. Coy-Dibley, Richard J. Miller, Daniela Maria Menichella · 2023 · Frontiers in Molecular Neuroscience
  46. Phagocytosis and self-destruction break down dendrites of Drosophila sensory neurons at distinct steps of Wallerian degeneration
    Hui Ji, Maria L. Sapar, Ankita Sarkar, Bei Wang, Chun Han · 2022 · Proceedings of the National Academy of Sciences
  47. TIR-1/SARM1 inhibits axon regeneration and promotes axon degeneration
    Victoria L Czech, Lauren O'Connor, Brendan Philippon, Emily K. Norman, Alexandra B. Byrne · 2023 · eLife
  48. SARM1-Dependent Axon Degeneration: Nucleotide Signaling, Neurodegenerative Disorders, Toxicity, and Therapeutic Opportunities
    Helen Ying McGuinness, Weixi Gu, Yun Yu Shi, Boštjan Kobe, Thomas Ve · 2023 · The Neuroscientist
  49. Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease
    Guo‐Lin Chen, Qi Ma, Dharmendra B. Goswami, Jianyu Shang, Gregory M. Miller · 2017 · Journal of Cellular and Molecular Medicine
  50. Advances in the Synthesis and Physiological Metabolic Regulation of Nicotinamide Mononucleotide
    Chuxiong Zheng, Yumeng Li, Xin Wu, Le Gao, Xiaoyi Chen · 2024 · Nutrients
  51. Subcellular proteomics and iPSC modeling uncover reversible mechanisms of axonal pathology in Alzheimer’s disease
    Yifei Cai, Jean E. Kanyo, Rashaun S. Wilson, Shveta Bathla, Pablo Leal Cardozo, Лей Тонг, Shanshan Qin, Lukas A. Fuentes, Iguaracy Pinheiro‐de‐Sousa, Tram Huynh et al. · 2025 · Nature Aging
  52. Role of pathogen's effectors in understanding host-pathogen interaction
    Abdul Waheed, Yakupjan Haxim, Waqar Islam, Gulnaz Kahar, Xiaojie Liu, Daoyuan Zhang · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  53. NAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
    Lucie Chanvillard, Alessandra Tammaro, Vincenzo Sorrentino · 2022 · Cells
  54. Use of electrospinning to construct biomaterials for peripheral nerve regeneration
    Qi Quan, Biao Chang, Hao Meng, Ruo Xi Liu, Yu Wang, Shi Bi Lu, Jiang Chen Peng, Qing Zhao · 2016 · Reviews in the Neurosciences
  55. Nicotinamide N-Methyltransferase (NNMT): A New Hope for Treating Aging and Age-Related Conditions
    Jingjing Li, Wei-Dong Sun, Xiaojuan Zhu, Ya-Zhong Mei, Wen-Song Li, Jiang-Hua Li · 2024 · Metabolites
  56. Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity
    Philipp Karschnia, Thomas Allen Nelson, Jörg Dietrich · 2025 · Nature reviews. Cancer
  57. Toll/interleukin-1 receptor domains in bacterial and plant immunity
    Sulin Li, Mohammad Kawsar Manik, Yun Yu Shi, Boštjan Kobe, Thomas Ve · 2023 · Current Opinion in Microbiology
  58. Targeting the programmed axon degeneration pathway as a potential therapeutic for Charcot-Marie-Tooth disease
    Kathryn R. Moss, Ahmet Höke · 2019 · Brain Research
  59. Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation
    Jing Wu, Kim Han, Michael N. Sack · 2024 · The Journal of Immunology
  60. Phosphorylation at S548 as a Functional Switch of Sterile Alpha and TIR Motif-Containing 1 in Cerebral Ischemia/Reperfusion Injury in Rats
    Tao Xue, Qing Sun, Yijie Zhang, Xin Wu, Haitao Shen, Xiang Li, Jiang Wu, Haiying Li, Zhong Wang, Gang Chen · 2020 · Molecular Neurobiology
  61. How activated NLRs induce anti-microbial defenses in plants
    Farid El Kasmi · 2021 · Biochemical Society Transactions
  62. Longitudinal and simultaneous profiling of 11 modes of cell death in mouse retina post-optic nerve injury
    Yao Yao, Yanxuan Xu, Jiajian Liang, Xi Zhuang, Tsz Kin Ng · 2022 · Experimental Eye Research
  63. The chemical biology of NAD+ regulation in axon degeneration
    Janneke D. Icso, Paul R. Thompson · 2022 · Current Opinion in Chemical Biology
  64. Mechanisms of the NAD+ salvage pathway in enhancing skeletal muscle function
    Mengzhu Su, Fanghui Qiu, Yansong Li, Tongtong Che, Ningning Li, Shuangshuang Zhang · 2024 · Frontiers in Cell and Developmental Biology
  65. Charcot–Marie–Tooth neuropathies: Current gene therapy advances and the route toward translation
    Marina Stavrou, Alexia Kagiava, Irene Sargiannidou, Elena Georgiou, Kleopas A. Kleopa · 2023 · Journal of the Peripheral Nervous System
  66. Complex role of nicotinamide adenine dinucleotide in the regulation of programmed cell death pathways
    Nicolas Preyat, Oberdan Léo · 2015 · Biochemical Pharmacology
  67. Rapid depletion of ESCRT protein Vps4 underlies injury-induced autophagic impediment and Wallerian degeneration
    Haiqiong Wang, Xuejie Wang, Kai Zhang, Qingyao Wang, Xu Cao, Zhao Wang, Shuang Zhang, Ang Li, Kai Liu, Yanshan Fang · 2019 · Science Advances
  68. Klebsiella pneumoniae emerging anti-immunology paradigms: from stealth to evasion
    Joana Sá‐Pessoa, Ricardo Calderón-González, Alix Lee, José Antonio Bengoechea · 2025 · Trends in Microbiology
  69. NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis
    Elena Obrador, Rosario Salvador Palmer, Rafael López‐Blanch, Ryan W. Dellinger, José M. Estrela · 2021 · Biomedicines
  70. A cluster of atypical resistance genes in soybean confers broad-spectrum antiviral activity
    Ting Yan, Zikai Zhou, Ru Wang, Duran Bao, Shanshan Li, Aoga Li, Ruonan Yu, Hada Wuriyanghan · 2021 · PLANT PHYSIOLOGY
  71. Mitochondrial behavior when things go wrong in the axon
    Victorio M. Pozo Devoto, Isaac G. Onyango, Gorazd Bernard Stokin · 2022 · Frontiers in Cellular Neuroscience
  72. Autophagy protein ULK1 interacts with and regulates SARM1 during axonal injury
    Harry Choi, Yun Li, Delwin Suraj, Ru‐ching Hsia, Chinmoy Sarkar, Junfang Wu, Marta M. Lipinski · 2022 · Proceedings of the National Academy of Sciences
  73. Corneal Denervation Causes Epithelial Apoptosis Through Inhibiting NAD + Biosynthesis
    Ya Li, Xiubin Ma, Jing Li, Lingling Yang, Xiaowen Zhao, Xia Qi, Xiaoping Zhang, Qingjun Zhou, Weiyun Shi · 2019 · Investigative Ophthalmology & Visual Science
  74. Early loss of endogenous NAD + following rotenone treatment leads to mitochondrial dysfunction and Sarm1 induction that is ameliorated by PARP inhibition
    Ankita Sarkar, Sourav Dutta, Malinki Sur, Semanti Chakraborty, Puja Dey, Piyali Mukherjee · 2022 · FEBS Journal
  75. Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells
    Nataliya A. Kolotyeva, Alexander A. Groshkov, Natalia A. Rozanova, Arseniy K. Berdnikov, Svetlana V. Novikova, Yulia K. Komleva, Alla Borisovna Salmina, Sergey Nikolaevich Illarioshkin, М. А. Пирадов · 2024 · Biomolecules
  76. Dynamic Aging: Channeled Through Microenvironment
    Qing Tan, Na Liang, Xiaoqian Zhang, Jun Li · 2021 · Frontiers in Physiology
  77. NAD+ Degrading Enzymes, Evidence for Roles During Infection
    Arnold Tan, Craig L. Doig · 2021 · Frontiers in Molecular Biosciences
  78. NMNAT2: An important metabolic enzyme affecting the disease progression
    Wentao Li, Mengxiang Gao, Chunhui Hu, Xiuwen Chen, Yanhong Zhou · 2022 · Biomedicine & Pharmacotherapy
  79. Cryo-EM structure of the ssDNA-activated SPARTA complex
    Minghui Guo, Yuwei Zhu, Zhiying Lin, Dehui Yang, Anqi Zhang, Changyou Guo, Zhiwei Huang · 2023 · Cell Research
  80. NAD + , Axonal Maintenance, and Neurological Disease
    Athanasios S. Alexandris, Vassilis E. Koliatsos · 2023 · Antioxidants and Redox Signaling
  81. Molecular mechanisms in the initiation phase of Wallerian degeneration
    Biao Chang, Qi Quan, Shibi Lu, Yu Wang, Jiang Peng · 2016 · European Journal of Neuroscience
  82. Benefits of Enhancing Nicotinamide Adenine Dinucleotide Levels in Damaged or Diseased Nerve Cells
    Andrew A. Pieper, Steven Lanier McKnight · 2018 · Cold Spring Harbor Symposia on Quantitative Biology
  83. The NAMPT enzyme employs a switch that directly senses AMP/ATP and regulates cellular responses to energy stress
    Yumeng Zu, Chou Wu, Feifei Li, Hong Yao, Yu Xia, Ruoxi Zhang, Lulu Li, Shuangquan Chen, Qi Shi, Shuang Xi et al. · 2025 · Molecular Cell
  84. SARM1 Ablation Is Protective and Preserves Spatial Vision in an In Vivo Mouse Model of Retinal Ganglion Cell Degeneration
    Laura K. Finnegan, Naomi Chadderton, Paul F. Kenna, Arpad Palfi, Michael Carty, Andrew Bowie, Sophia Millington‐Ward, Gwyneth Jane Farrar · 2022 · International Journal of Molecular Sciences
  85. Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy
    Min‐Jee Kim, Hyeyoung Kim, Bu-Gyeong Kang, Joo‐Young Lee, Taegun Kim, Hwanho Lee, Jane Jung, Myung Joon Oh, Seungyoon Seo, Myung‐Jeom Ryu et al. · 2023 · Theranostics
  86. Diabetic polyneuropathy: Bridging the translational gap
    Masaki Kobayashi, Douglas William Zochodne · 2020 · Journal of the Peripheral Nervous System
  87. Neurotoxin-mediated --potent activation of the axon degeneration regulator SARM1.
    Andrea Loreto, Angeletti, Carlo, Weixi Gu, Andrew Osborne, Bart Nieuwenhuis, Jonathan Gilley, Elisa Merlini, Peter Arthur‐Farraj, Adolfo Amici, Zhenyao Luo et al. · 2021 · Apollo (University of Cambridge)
  88. Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective
    Yu Fan, Huiying Zhao, Luo Lu, Wei Wu · 2025 · Nutrients
  89. METTL1-mediated m 7 G methylation of Sarm1 mRNA promotes macrophage inflammatory responses and multiple organ injury
    Chao Hou, Xinru Zhang, Jie Wei, Jia-nan Wang, Jian Gao, Zhi-juan Wang, Shuai-shuai Xie, Tong Chen, Tao Sun, Tian Pu et al. · 2025 · Science Immunology
  90. Subcellular localization requirements and specificities for plant immune receptor Toll‐interleukin‐1 receptor signaling
    Maud Bernoux, Jian Chen, Xiaoxiao Zhang, Kim Newell, Jian He Hu, Laurent Deslandes, Peter N. Dodds · 2023 · The Plant Journal
  91. SARM1 promotes the neuroinflammation and demyelination through IGFBP2 / NF‐κB pathway in experimental autoimmune encephalomyelitis mice
    Jingjing Zhang, Lingting Jin, Xin Hua, Mianxian Wang, Jiaojiao Wang, Xingxing Xu, Huitao Liu, Haoyu Qiu, Huankun Sun, Tianyingying Dong et al. · 2023 · Acta Physiologica
  92. NAD+: An old but promising therapeutic agent for skeletal muscle ageing
    Yingying Xu, Weihua Xiao · 2023 · Ageing Research Reviews
  93. Axonal degeneration in an in vitro model of ischemic white matter injury
    Yuexian Cui, Xuelian Jin, Dong‐Joo Choi, Jun Young Choi, Hyung Soon Kim, Dong Hoon Hwang, Byung Gon Kim · 2019 · Neurobiology of Disease
  94. A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria
    Konstantin Feinberg, Adelaida Kolaj, Chen Wu, Natalie Grinshtein, Jonathan R. Krieger, Michael F. Moran, Lee L. Rubin, Freda D. Miller, David R. Kaplan · 2017 · The Journal of Cell Biology
  95. An overview of ongoing clinical trials assessing pharmacological therapeutic strategies to manage chemotherapy‐induced peripheral neuropathy, based on preclinical studies in rodent models
    Hichem Bouchenaki, Aurore Danigo, Franck G. Sturtz, Rodolphe Hajj, Laurent Magy, Claire Demiot · 2020 · Fundamental and Clinical Pharmacology
  96. Neuroinflammation: Breaking barriers and bridging gaps
    Lora A. Estera, Sam P. Walsh, Jordan A. Headen, Rachel E. Williamson, Ashley L. Kalinski · 2021 · Neuroscience Research
  97. Bortezomib-induced neurotoxicity in human neurons is the consequence of nicotinamide adenine dinucleotide depletion
    Andrew R. Snavely, Keungjung Heo, Veselina Petrova, Tammy Szu‐Yu Ho, Xuan Huang, Crystal Hermawan, Ruth D. Kagan, Tao Deng, Ilyas Singeç, Long Chen et al. · 2022 · Disease Models & Mechanisms
  98. Traumatic Axonal Injury in the Optic Nerve: The Selective Role of SARM1 in the Evolution of Distal Axonopathy
    Athanasios S. Alexandris, Youngrim Lee, Mohamed Lehar, Zahra Alam, James McKenney, Dianela Perdomo, Jiwon Ryu, Derek S. Welsbie, Donald J. Zack, Vassilis E. Koliatsos · 2023 · Journal of Neurotrauma
  99. Divergent signaling requirements of dSARM in injury-induced degeneration and developmental glial phagocytosis
    Kelsey A. Herrmann, Yizhou A. Liu, Arnau Llobet Rosell, Colleen N. McLaughlin, Lukas Jakob Neukomm, Jaeda Coutinho‐Budd, Heather Tarczy Broihier · 2022 · PLoS Genetics
  100. Degeneration of Injured Axons and Dendrites Requires Restraint of a Protective JNK Signaling Pathway by the Transmembrane Protein Raw
    Yan Hao, Thomas J. Waller, Derek M. R. Nye, Jiaxing Li, Yanxiao Zhang, Richard I. Hume, Melissa M. Rolls, Catherine A. Collins · 2019 · Journal of Neuroscience